SynOx Therapeutics

Share on: 
Description: 

SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of therapies to treat cancer. SynOx is developing  emactuzumab, a CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue.

Location(s): 
Dublin
Ireland